CDNS vs INMB · P/E 82, rev $5.30B vs rev $50.0K
Cadence Design Systems Inc (CDNS) versus INmune Bio Inc (INMB) — a side-by-side from cached financials, not a winner call.
Cadence Design Systems Inc (CDNS) is a software - application company listed on US.
INmune Bio Inc (INMB) is a biotechnology company listed on US.
Latest reported CDNS revenue for 2025-12-31 was $5.30B. Net income was $1.11B. Revenue was up 14.1% from 2024-12-31 to 2025-12-31. CDNS currently screens at market cap $88.27B and trailing P/E 82.0.
Latest reported INMB revenue for 2025-09-30 was $50.0K. Net income was -$6.5M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. INMB currently screens at market cap $33.5M.
CDNS currently screens at market cap $88.27B and trailing P/E 82.0. INMB currently screens at market cap $33.5M.
Not investment advice. Open the CDNS and INMB stock pages for the full models.
Not investment advice.